Spinning loader
  • Slide number 0

    Networked

    Digital generiertes Netzwerk

  • Slide number 1

    Experienced

    Makroaufnahme Glasfaser

  • Slide number 2

    Versatile

    Makroaufnahme Buch

  • Slide number 3

    Structured

    Digital generiertes Molekülmodell

  • Slide number 4

    Precise

    Makroaufnahme Uhrwerk

 
  • Rentsch Partner

Christian Ebner

Functions:
Associates, Management
Title:
Business Development
Profile Pictures:
Memberships:
  • Link EPI

    Institute of Professional Representatives before the European Patent Office

  • Link VESPA

    Association of European Patent Attorneys in Switzerland (private practise)

  • Link VSP

    Association of Swiss Patent and Trademark Attorneys
Publications:
  • Christian Ebner, Axel Remde, Alfred Köpf
    Limitations on Patentability for Medical Devices

    Part 1 (PDF) / Part 2 (PDF)

    20 October 2023
  • Louis Lagler, Christian Ebner
    Important Aspects of IP for Start-Ups: Strategies for Avoiding Common Pitfalls

    In: Bader, M.A., Süzeroğlu-Melchiors, S. (eds) Intellectual Property Management for Start-ups. Management for Professionals. Springer, Cham., Februar 2023 (Link zum Buch)

    09 March 2023
  • Christian Ebner, Moritz Hönig
    Aktuelles aus der Schweiz

    Mitteilungen der deutschen Patentanwälte - Heft 2|2023

    09 February 2023
  • Christian Ebner, Demian Stauber, Alfred Köpf
    Exhaustion of Method Patents in Switzerland: “Sell Someone an Inch and They’ll Take a Mile”?

    Life Science Recht Nr. 4, 2022, S. 243-250 (Link zum Beitrag)

    10 November 2022
  • Christian Ebner, Alfred Köpf, Moritz Hönig
    Challenges and Opportunities in Licensing Biotech-Research Tools

    Life Science Recht Nr. 4, 2021, S. 199–207 (Link)

    23 November 2021
  • Christian Ebner, Alfred Köpf, Axel Remde
    Medical Devices and the Exclusion from Patentability

    Life Science Recht Nr. 2, 2021, S. 71–80 (Link)

    23 November 2021
  • Christian Ebner, Alfred Köpf
    Opinion G 3/19 of the Enlarged Board of Appeal

    Life Science Recht Nr. 3, 2020, S. 168 ff.

    27 November 2020
  • Alfred Köpf, Christian Ebner
    The Concept of Plausibility in Patent Law

    Life Science Recht Nr.1 2020, 45-51

    26 March 2020
  • Alfred Köpf, Christian Ebner
    Case Law of the Swiss Federal Patent Court in 2018

    Life Science Recht Nr. 4, 2019, 262 ff.

    06 November 2019
  • Alfred Köpf, Christian Ebner
    Patentability of Plants after T 1063/18

    sic! 2019, 7/8, S. 457 ff.

    23 August 2019
  • Alfred Köpf, Christian Ebner
    Genome Editing – Upcoming Challenges for Life Sciences Law

    Life Science Recht Nr. 1, 2019, S. 64 ff.

    06 February 2019
  • Alfred Köpf, Christian Ebner
    Decision G 1/16 of the Enlarged Board of Appeal of the European Patent Office – Disclaimer III

    sic! 2018, 500 ff.

    13 September 2018
  • Alfred Köpf, Christian Ebner
    Case Law of the Federal Patent Court – Selected Decisions in 2017

    Life Science Recht Nr. 3, 2018, S. 213 ff.

    17 July 2018
Blog posts:

  • Christian Ebner
    Sell or Rent?
    Sell or Rent? Does it impact your intellectual property? Yes! It is a business decision which may strongly affect your IP
    06 March 2024
  • Christian Ebner
    No patent protection in Europe for plants obtained by CRISPR and related technologies?
    The Members of the EU Parliament have agreed to adapt the rules for NGT plants (New Genomic Techniques, i.e. plants which have been obtained by genetic engineering tools, such as CRISPR/Cas). In their proposal, the MEPs aim to introduce a complete exclusion from patentability for all NGT plants. The intention behind seems to be to avoid legal uncertainties and dependencies for farmers and breeders.
    22 February 2024
  • Moritz Hönig, Christian Ebner , Alfred Köpf
    Challenges in licensing CRISPR gene editing
    Is a license required for CRISPR gene editing? If yes, how do I get one? In this article, some of the challenges in licensing CRISPR gene editing are discussed.
    05 April 2022
  • Andrea Carreira, Christian Ebner
    Ausreichende Offenbarung: von zentraler Bedeutung für Erstanmeldungen
    Patent-Erstanmeldungen wird oft zu wenig Bedeutung beigemessen. Dabei zählt das Verfassen der Erstanmeldung zu den kritischsten Aufgaben eines Patentanwaltes oder einer Patentanwältin. Andrea Carreira und Christian Ebner schreiben über die zentrale Bedeutung der Erstanmeldung.
    16 April 2021
  • Christian Ebner, Andrea Carreira
    The Success Story of a Life Science Startup
    How can startups protect their inventions? Christian Ebner and Andrea Carreira tell the success story of a swiss startup.
    15 July 2020
Contact
Christian Ebner
Position:
Senior Associate
Address:
Rentsch Partner AG
Kirchenweg 8
Zürich
8008
Phone:
+41 44 225 70 70
Send an Email
(optional)
Fields
(optional)
(optional)
Miscellaneous Information:

Senior Associate I Dr. sc. ETH, MSc ETH Chemistry, European and Swiss Patent Attorney, European Patent Litigator

Working as a European Patent Attorney, Christian Ebner focuses on chemistry, biotechnology, medicinal technology, process technology and mechanics.

Christian Ebner studied chemistry at ETH Zurich and specialized in the field of complex organic synthesis. After his Master thesis at the Scripps Research Institute in La Jolla, USA, he conducted his graduate studies at the Laboratory of Organic Chemistry at ETH Zurich. His dissertation focused on the area of natural product synthesis, reaction development and the synthesis of bioactive target molecules. Christian Ebner joined RENTSCH PARTNER in January 2017.